Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease

31 Jul 2023

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD) affects about 20–40% of the adult population in high-income countries and is now a leading indication for liver transplantation and can lead to hepatocellular carcinoma. The link between gut microbiota dysbiosis and NAFLD is now clearly established. Through analyses of the gut microbiota with shotgun metagenomics, we observe that compared to healthy controls,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet and metabolism studies
Share to Gut microbiota and health
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37569608
DOI: 10.3390/ijms241512232

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver DiseasePMID 37569608Read ↗

Gut microbiome and NAFLD: impact and therapeutic potentialSemantic proximity Read ↗

Gut Microbiota Patterns in Patients with Non-Alcoholic Fatty Liver Disease: A Comprehensive Assessment Using Three Analysis MethodsSemantic proximity Read ↗

From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patientsSemantic proximity Read ↗

Bacteroides uniformis-generated hexadecanedioic acid ameliorates metabolic-associated fatty liver diseaseSemantic proximity Read ↗

Autoimmune Hepatitis: Shifts in Gut Microbiota and Metabolic Pathways among Egyptian PatientsSemantic proximity Read ↗

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity Read ↗

Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?Semantic proximity Read ↗

Insights from shotgun metagenomics into bacterial species and metabolic pathways associated with NAFLD in obese youthSemantic proximity Read ↗

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapiesSemantic proximity Read ↗

Comparative genomics and functional characterization of 11 newly isolated non-equol-producing Adlercreutzia strains with anti-inflammatory propertiesSemantic proximity Read ↗

E. coli NF73-1 Isolated From NASH Patients Aggravates NAFLD in Mice by Translocating Into the Liver and Stimulating M1 PolarizationSemantic proximity Read ↗

Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.